APA (7th ed.) Citation

VC, G., CE, N., CJ, B., & AC, F. (2022). Editorial: Estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' reply. Alimentary pharmacology & therapeutics, 55(12), 1590. https://doi.org/10.1111/apt.16966

Chicago Style (17th ed.) Citation

VC, Goodoory, Ng CE, Black CJ, and Ford AC. "Editorial: Estimating the Costs of Care in Irritable Bowel Syndrome-a Necessary Step to Enhance Value-based Care for a High-prevalence, Low-cost Condition. Authors' Reply." Alimentary Pharmacology & Therapeutics 55, no. 12 (2022): 1590. https://doi.org/10.1111/apt.16966.

MLA (9th ed.) Citation

VC, Goodoory, et al. "Editorial: Estimating the Costs of Care in Irritable Bowel Syndrome-a Necessary Step to Enhance Value-based Care for a High-prevalence, Low-cost Condition. Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 55, no. 12, 2022, p. 1590, https://doi.org/10.1111/apt.16966.